AAAAAA
Results:
1-14
|
Results: 14
Authors:
ZIEGLER JL
NEWTON R
KATONGOLEMBIDDE E
MBULATAIYE S
DECOCK K
WABINGA H
MUGERWA J
KATABIRA E
JAFFE H
PARKIN DM
REEVES G
WEISS R
BERAL V
Citation: Jl. Ziegler et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN HIV-POSITIVE SUBJECTS IN UGANDA, AIDS, 11(13), 1997, pp. 1619-1626
Authors:
PURVIS SF
KATONGOLEMBIDDE E
JOHNSON JL
LEONARD DGB
BYABAZAIRE N
LUCKEY C
SCHICK HE
WALLIS R
ELMETS CA
GIAM CZ
Citation: Sf. Purvis et al., HIGH-INCIDENCE OF KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS AND EPSTEIN-BARR-VIRUS IN TUMOR LESIONS AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH KAPOSIS-SARCOMA IN UGANDA, The Journal of infectious diseases, 175(4), 1997, pp. 947-950
Authors:
GRANT RM
PIWOWAR EM
KATONGOLEMBIDDE E
MUZAWALU W
RUGERA S
ABIMA J
STRAMER SL
KATAAHA P
JACKSON B
Citation: Rm. Grant et al., COMPARISON OF SALIVA AND SERUM FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIBODY TESTING IN UGANDA USING A RAPID RECOMBINANT ASSAY, Clinical and diagnostic laboratory immunology, 3(6), 1996, pp. 640-644
Authors:
ZIEGLER JL
KATONGOLEMBIDDE E
Citation: Jl. Ziegler et E. Katongolembidde, DIMINISHED DELAYED-HYPERSENSITIVITY RESPONSES IN THE LEGS AND FEET OFPATIENTS WITH ENDEMIC KAPOSIS-SARCOMA, Transactions of the Royal Society of Tropical Medicine and Hygiene, 90(2), 1996, pp. 173-174
Authors:
CHUCK S
GRANT RM
KATONGOLEMBIDDE E
CONANT M
GANEM D
Citation: S. Chuck et al., FREQUENT PRESENCE OF A NOVEL HERPESVIRUS GENOME IN LESIONS OF HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE KAPOSIS-SARCOMA, The Journal of infectious diseases, 173(1), 1996, pp. 248-251
Authors:
ZIEGLER JL
KATONGOLEMBIDDE E
Citation: Jl. Ziegler et E. Katongolembidde, KAPOSIS-SARCOMA IN CHILDHOOD - AN ANALYSIS OF 100 CASES FROM UGANDA AND RELATIONSHIP TO HIV-INFECTION, International journal of cancer, 65(2), 1996, pp. 200-203
Authors:
TUGUME SB
PIWOWAR EM
LUTALO T
MUGYENYI PN
GRANT RM
MANGENI FW
PATTISHALL K
KATONGOLEMBIDDE E
Citation: Sb. Tugume et al., HEMATOLOGICAL REFERENCE RANGES AMONG HEALTHY UGANDANS, Clinical and diagnostic laboratory immunology, 2(2), 1995, pp. 233-235
Authors:
PIWOWAR EM
TUGUME SB
GRANT RM
LUTALO T
PATTISHALL K
KATONGOLEMBIDDE E
Citation: Em. Piwowar et al., BETA-2-MICROGLOBULIN VALUES AMONG HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-NEGATIVE, HIV-POSITIVE ASYMPTOMATIC, AND HIV-POSITIVE SYMPTOMATIC UGANDANS, Clinical and diagnostic laboratory immunology, 2(2), 1995, pp. 236-237
Authors:
LOUID LG
DESMONDHELLMANN S
HELLMANN N
KIZITOMUYOMBYA A
KATONGOLEMBIDDE E
TAGER IB
Citation: Lg. Louid et al., ASSOCIATION OF KS WITH A LATENT SEXUALLY-TRANSMITTED AGENT, Journal of cellular biochemistry, 1995, pp. 258-258
Authors:
RILEY JP
PESTANO GA
HOSFORD K
FRANCIS C
XIE JM
MUGYENYI P
KATAAHA P
KATONGOLEMBIDDE E
ANOKBONGGO WW
GUYDEN J
BOTO WMO
Citation: Jp. Riley et al., RELATIVE REACTIVITY OF THE V3 LOOP PND OF HIV-1 SUBTYPE-A, SUBTYPE-B,SUBTYPE-C, SUBTYPE-D, AND SUBTYPE-F WITH SERA FROM SELECTED UGANDAN LOCALITIES, Archives of virology, 140(8), 1995, pp. 1393-1404
Authors:
ZIEGLER JL
KATONGOLEMBIDDE E
WABINGA H
DOLLBAUM CM
Citation: Jl. Ziegler et al., ABSENCE OF SEX-HORMONE RECEPTORS IN KAPOSIS-SARCOMA, Lancet, 345(8954), 1995, pp. 925-925
Authors:
KATONGOLEMBIDDE E
Citation: E. Katongolembidde, PREPARATIONS FOR AIDS VACCINE TRIALS - RESPECTING CONCERNS OF INTERNATIONAL HOST COUNTRIES, AIDS research and human retroviruses, 10, 1994, pp. 190000187-190000189
Authors:
LURIE P
BISHAW M
CHESNEY MA
COOKE M
FERNANDES MEL
HEARST N
KATONGOLEMBIDDE E
KOETSAWANG S
LINDAN CP
MANDEL J
MHLOYI M
COATES TJ
Citation: P. Lurie et al., ETHICAL, BEHAVIORAL, AND SOCIAL ASPECTS OF HIV VACCINE TRIALS IN DEVELOPING-COUNTRIES, JAMA, the journal of the American Medical Association, 271(4), 1994, pp. 295-301
Authors:
KATONGOLEMBIDDE E
Citation: E. Katongolembidde, EXPECTATIONS OF HOST COUNTRIES IN HIV VACCINE TRIALS, AIDS research and human retroviruses, 9, 1993, pp. 190000017-190000019
Risultati:
1-14
|